Prof Neil Bressler
James P. Gills Professor of Ophthalmology
Position: James P. Gills Professor of Ophthalmology
Specialization: Retinal Diseases, Diabetic Retinopathy, Macular Degeneration
Affiliation: Wilmer Eye Institute, Johns Hopkins University School of Medicine
Biography
Dr. Neil Bressler has been a member of the Wilmer Eye Institute's faculty since 1988 and is the inaugural James P. Gills Professor of Ophthalmology. He specializes in retinal diseases, with special interests in diabetic retinopathy and macular degeneration.
Dr. Bressler's main research interests have been collaborative efforts in clinical trials of common retinal diseases, including age-related macular degeneration and diabetic retinopathy, having chaired several NIH-sponsored and industry-sponsored multicenter randomized clinical trials and authored almost 300 peer-reviewed publications.
Key Research Areas
- Retinal diseases and disorders
- Diabetic retinopathy
- Age-related macular degeneration
- Clinical trials in ophthalmology
- Multicenter randomized clinical trials
Leadership Roles
- Past Chair, NIH-sponsored Diabetic Retinopathy Clinical Research Network
- Chair, National Eye Institute's Data and Safety Monitoring Committee for intramural clinical trials
- Chair, FDA Ophthalmic Devices Panel
- Editor-in-Chief, JAMA Ophthalmology
Research Contributions
As past chair of the NIH-sponsored Diabetic Retinopathy Clinical Research Network, Dr. Bressler was responsible for guidelines, policies, protocol development as well as implementation, and to facilitate Network operations in a way that maintains academic integrity and optimal clinical trial performance.
He has chaired several NIH-sponsored and industry-sponsored multicenter randomized clinical trials, contributing significantly to the advancement of treatment options for retinal diseases.
Academic Achievements
- Author of almost 300 peer-reviewed publications
- Inaugural James P. Gills Professor of Ophthalmology
- Faculty member at Wilmer Eye Institute since 1988
- Leadership in major clinical trial networks